MiRNA-related SNPs and risk of esophageal adenocarcinoma and Barrett's esophagus: Post genome-wide association analysis in the BEACON Consortium

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Buas, Matthew F ^a   Onstad, Lynn ^a   Levine, David M ^b   Risch, Harvey A ^c   Chow, Wong Ho ^d   Liu, Geoffrey ^e   Fitzgerald, Rebecca C ^f   Bernstein, Leslie ^g   Ye, Weimin ^h   Bird, Nigel C ⁱ   Romero, Yvonne ^j   Casson, Alan G ^k   Corley, Douglas A ^l,m   Shaheen, Nicholas J ⁿ   Wu, Anna H ^o   Gammon, Marilie D ^p   Reid, Brian J ^a   Hardie, Laura J ^q   Peters, Ulrike ^a,b   Whiteman, David C ^r   Vaughan, Thomas L ^a,b   more..

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c YALE UNIVERSITY   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e PRINCESS MARGARET HOSPITAL   (Canada)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^g CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ UNIVERSITY OF SHEFFIELD   (United Kingdom)

^j MAYO CLINIC   (United States)

^k UNIVERSITY OF SASKATCHEWAN   (Canada)

^l DIVISION OF RESEARCH   (United States)

^m San Francisco Medical Center   (United States)

ⁿ UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^p IL   (United States)

^q UNIVERSITY OF LEEDS   (United Kingdom)

^r QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; SMALL UNTRANSLATED RNA;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BIOGENESIS; BIOLOGICAL ACTIVITY; CANCER RISK; CONTROLLED STUDY; DISEASE PREDISPOSITION; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GENE CONTROL; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; RISK ASSESSMENT; RISK FACTOR; RNA GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ADENOCARCINOMA; CASE CONTROL STUDY; CAUCASIAN; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; ETHNOLOGY; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION REGULATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; SEX DIFFERENCE;

NICOTIANA TABACUM;

ADENOCARCINOMA; AGED; BARRETT ESOPHAGUS; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION REGULATION; GENETIC LOCI; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MICRORNAS; MIDDLE AGED; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 84934997482     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128617     Document Type: Article

References (74)

1. Holmes RS, Vaughan TL. Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol. 2007;17:2-9. PMID: 17185192
2. Reid BJ, Li X, Galipeau PC, Vaughan TL. Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis. Nat Rev Cancer. Nature Publishing Group; 2010;10:87-101. doi: 10.1038/nrc2773 PMID: 20094044
3. Moons LM, Kuipers EJ, Rygiel AM, Groothuismink AZ, Geldof H, Bode WA, et al. {COX-2} {CA-haplotype} is a risk factor for the development of esophageal adenocarcinoma. Am J Gastroenterol. 2007;102:2373-2379. PMID: 17581270
4. Kristinsson JO, Van Westerveld P, Te Morsche RH, Roelofs HM, Wobbes T, Witteman BJ, et al. Cyclooxygenase-2 polymorphisms and the risk of esophageal adeno- or squamous cell carcinoma. World J Gastroenterol. 2009;15:3493-3497. Available: http://www.ncbi.nlm.nih.gov/pubmed/19630103 PMID: 19630103
5. Babar M, Ryan AW, Anderson LA, Segurado R, Turner G, Murray LJ, et al. Genesoftheinterleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma. Am J Gastroenterol. 2012;107:1331-1341. doi: 10.1038/ajg.2012.134 PMID: 22664470
6. Menke V, Van Zoest KP, Moons LM, Hansen B, Pot RG, Siersema PD, et al. {NcoI} {TNF-fi} gene polymorphism and {TNF} expression are associated with an increased risk of developing Barrett's esophagus and esophageal adenocarcinoma. Scand J Gastroenterol. 2012;47:378-386. doi: 10.3109/00365521.2011.650192 PMID: 22243485
7. Casson AG, Zheng Z, Porter GA, Guernsey DL. Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma. Cancer Detect Prev. 2006;30:423-431. PMID: 17064856
8. Bull LM, White DL, Bray M, Nurgalieva Z, El-Serag HB. Phase I and {II} enzyme polymorphisms as risk factors for Barrett's esophagus and esophageal adenocarcinoma: a systematic review and meta-analysis. Dis Esophagus. 2009;22:571-587. doi: 10.1111/j.1442-2050.2009.00947.x PMID: 19222528
9. Di Martino E, Hardie LJ, Wild CP, Gong YY, Olliver JR, Gough MD, et al. The{NAD (P) H:quinone}oxidoreductase I {C609T} polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma. Genet Med. 2007;9:341-347. PMID: 17575500
10. Doecke J, Zhao ZZ, Pandeya N, Sadeghi S, Stark M, Green AC, et al. Polymorphisms in {MGMT} and {DNA} repair genes and the risk of esophageal adenocarcinoma. IntJ Cancer. 2008;123:174-180. doi: 10.1002/ijc.23410 PMID: 18386788
11. Zhai R, Liu G, Asomaning K, Su L, Kulke MH, Heist RS, et al. Genetic polymorphisms of {VEGF}, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis. 2008;29:2330-2334. doi: 10.1093/carcin/bgn210 PMID: 18780893
12. Cheung WY, Zhai R, Bradbury P, Hopkins J, Kulke MH, Heist RS, et al. Single nucleotide polymorphisms in the matrix metalloproteinase gene family and the frequency and duration of gastroesophageal reflux disease influence the risk of esophageal adenocarcinoma. IntJ Cancer. 2012;
13. Liu CY, Wu MC, Chen F, Ter-Minassian M, Asomaning K, Zhai R, et al. A Large-scale genetic association study of esophageal adenocarcinoma risk. Carcinogenesis. 2010;31:1259-1263. doi: 10.1093/carcin/bgq092 PMID: 20453000
14. Orloff M, Peterson C, He X, Ganapathi S, Heald B, Yang Y, et al. Germline mutations in MSR1, ASCC1, and CTHRC1 in patients with Barrett esophagus and esophageal adenocarcinoma. JAMA. 2011;306:410-419. doi: 10.1001/jama.2011.1029 PMID: 21791690
15. Su Z, Gay LJ, Strange A, Palles C, Band G, Whiteman DC, et al. Common variants at the {MHC} locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet. 2012;44:1131-1136. doi: 10.1038/ng.2408 PMID: 22961001
16. Levine DM, Ek WE, Zhang R, Liu X, Onstad L, Sather C, et al. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet. 2013;45:1487-93. doi: 10.1038/ng.2796 PMID: 24121790
17. Ek WE, Levine DM, Amato MD, Pedersen NL, Magnusson PKE, Bresso F, et al. Germline Genetic Contributions to Risk for Esophageal Adenocarcinoma, Barrett's Esophagus, and Gastroesophageal Reflux. J Natl Cancer Inst. 2013;105:1711-1718. doi: 10.1093/jnci/djt303 PMID: 24168968
18. Palles C, Chegwidden L, Li X, Findlay JM, Farnham G, Giner FC, et al. Polymorphisms NearTBX5 and GDF7Are Associated With Increased Risk for Barrett's Esophagus. Gastroenterology. 2014;
19. Pasquinelli AE. {MicroRNAs} and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet. 2012;13:271-282. doi: 10.1038/nrg3162 PMID: 22411466
20. Di Leva G, Garofalo M, Croce CM. MicroRNAs in cancer. Annu Rev Pathol. 2014;9:287-314. doi: 10. 1146/annurev-pathol-012513-104715 PMID: 24079833
21. Hulsmans M, De Keyzer D, Holvoet P. {MicroRNAs} regulating oxidative stress and inflammation in relation to obesity and atherosclerosis. {FASEB} J. 2011;25:2515-2527. doi: 10.1096/fj.11-181149 PMID: 21507901
22. Contreras J, Rao DS. {MicroRNAs} in inflammation and immune responses. Leukemia. 2012;26:404-413. doi: 10.1038/leu.2011.356 PMID: 22182919
23. Bansal A, Hong X, Lee I-H, Krishnadath KK, Mathur SC, Gunewardena S, et al. MicroRNA Expression can be a Promising Strategy for the Detection of Barrett's Esophagus: A Pilot Study. ClinTransl Gastroenterol. Nature Publishing Group; 2014;5:e65. doi: 10.1038/ctg.2014.17 PMID: 25502391
24. Wu X, Ajani JA, Gu J, Chang DW, Tan W, Hildebrandt MA, et al. {MicroRNA} expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer Prev Res. 2013;6:196-205. doi: 10.1158/1940-6207. CAPR-12-0276 PMID: 23466817
25. Bansal A, Lee IH, Hong X, Mathur SC, Tawfik O, Rastogi A, et al. Discovery and validation of Barrett's esophagus {microRNA} transcriptome by next generation sequencing. {PLoS}One. 2013;8:e54240. doi: 10.1371/journal.pone.0054240 PMID: 23372692
26. Saad R, Chen Z, Zhu S, Jia P, Zhao Z, Washington MK, et al. Deciphering the Unique {MicroRNA} Signature in Human Esophageal Adenocarcinoma. {PloS}one. 2013;8:e64463. doi: 10.1371/journal. pone.0064463 PMID: 23724052
27. Streppel MM, Pai S, Campbell NR, Hu C, Yabuuchi S, Canto MI, et al. microRNA223 Is Upregulated in the Multistep Progression of Barrett's Esophagus and Modulates Sensitivity to Chemotherapy by Targeting PARP1. Clin Cancer Res. 2013;19:4067-4078. doi: 10.1158/1078-0432. CCR-13-0601 PMID: 23757351
28. Garman KS, Owzar K, Hauser ER, Westfall K, Anderson BR, Souza RF, et al. MicroRNA expression differentiates squamous epithelium from Barrett's esophagus and esophageal cancer. Dig Dis Sci. 2013;58:3178-88. doi: 10.1007/s10620-013-2806-7 PMID: 23925817
29. Revilla-Nuin B, Parrilla P, Lozano JJ, De Haro LFM, Ortiz A, Martínez C, et al. Predictive value of Micro-RNAs in the progression of barrett esophagus to adenocarcinoma in a long-term follow-up study. Ann Surg. 2013;257:886-93. doi: 10.1097/SLA.0b013e31826ddba6 PMID: 23059500
30. Sakai NS, Samia-Aly E, Barbera M, Fitzgerald RCA review of the current understanding and clinical utility of miRNAs in esophageal cancer. Semin Cancer Biol. Elsevier Ltd; 2013;23:512-21. doi: 10. 1016/j.semcancer.2013.08.005 PMID: 24013023
31. Leidner RS, Ravi L, Leahy P, Chen Y, Bednarchik B, Streppel M, et al. The {microRNAs}, {MiR-31}and {MiR-375}, as candidate markers in Barrett's esophageal carcinogenesis. Genes Chromosom Cancer. 2012;51:473-479. doi: 10.1002/gcc.21934 PMID: 22302717
32. Fassan M, Volinia S, Palatini J, Pizzi M, Baffa R, De Bernard M, et al. {MicroRNA} expression profiling in human Barrett's carcinogenesis. Int J Cancer. 2011;129:1661-1670. doi: 10.1002/ijc.25823 PMID: 21128279
33. Nguyen GH, Schetter AJ, Chou DB, Bowman ED, Zhao R, Hawkes JE, et al. Inflammatory and {micro-RNA} gene expression as prognostic classifier of Barrett's-associated esophageal adenocarcinoma. Clin Cancer Res. 2010;16:5824-5834. doi: 10.1158/1078-0432. CCR-10-1110 PMID: 20947516
34. Wijnhoven BP, Hussey DJ, Watson DI, Tsykin A, Smith CM, Michael MZ, et al. {MicroRNA} profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br J Surg. 2010;97:853-861. doi: 10.1002/bjs.7000 PMID: 20301167
35. Mathé EA, Nguyen GH, Bowman ED, Zhao Y, Budhu A, Schetter AJ, et al. {MicroRNA}expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res. 2009;15:6192-6200. doi: 10.1158/1078-0432. CCR-09-1467 PMID: 19789312
36. Yang H, Gu J, Wang KK, Zhang W, Xing J, Chen Z, et al. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clin Cancer Res. 2009;15:5744-52. doi: 10.1158/1078-0432CCR-09-0385 PMID: 19737949
37. Maru DM, Singh RR, Hannah C, Albarracin CT, Li YX, Abraham R, et al. {MicroRNA-196a} is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am J Pathol. 2009;174:1940-1948. doi: 10.2353/ajpath.2009.080718 PMID: 19342367
38. Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, et al. {MicroRNA}expression profiles of esophageal cancer. J Thorac Cardiovasc Surg. 2008;135:255-60; discussion 260. doi: 10.1016/j. jtcvs.2007.08.055 PMID: 18242245
39. Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010;10:389-402. doi: 10.1038/nrc2867 PMID: 20495573
40. Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA, et al. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res (Phila). 2008;1:460-9. doi: 10. 1158/1940-6207. CAPR-08-0135 PMID: 19138993
41. Buas MF, Levine DM, Makar KW, Utsugi H, Onstad L, Li X, et al. Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. Carcinogenesis. 2014;35:2740-2747. doi: 10.1093/carcin/bgu207 PMID: 25280564
42. Amos CI, Wang L-E, Lee JE, Gershenwald JE, Chen WV, Fang S, et al. Genome-wide association study identifies novel loci predisposing to cutaneous melanoma. Hum Mol Genet. 2011;20:5012-23. doi: 10.1093/hmg/ddr415 PMID: 21926416
43. Laurie CC, Doheny KF, Mirel DB, Pugh EW, Bierut LJ, Bhangale T, et al. Quality control and quality assurance in genotypic data for genome-wide association studies. Genet Epidemiol. 2010;34:591-602. doi: 10.1002/gepi.20516 PMID: 20718045
44. Thomas LF, Saito T, Sætrom P. Inferring causative variants in {microRNA} target sites. Nucleic Acids Res. 2011;39:e109. doi: 10.1093/nar/gkr414 PMID: 21693556
45. Landi D, Gemignani F, Barale R, Landi S. A catalog of polymorphisms falling in {microRNA-binding} regions of cancer genes. {DNA} Cell Biol. 2008;27:35-43.
46. Pelletier C, Weidhaas JB. {MicroRNA} binding site polymorphisms as biomarkers of cancer risk. Expert Rev Mol Diagn. 2010;10:817-829. doi: 10.1586/erm.10.59 PMID: 20843204
47. Nicoloso MS, Sun H, Spizzo R, Kim H, Wickramasinghe P, Shimizu M, et al. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res. 2010;70:2789-98. doi: 10.1158/0008-5472. CAN-09-3541 PMID: 20332227
48. Liang D, Meyer L, Chang DW, Lin J, Pu X, Ye Y, et al. Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response. Cancer Res. 2010;70:9765-76. doi: 10.1158/0008-5472. CAN-10-0130 PMID: 21118967
49. Zhou X, Chen X, Hu L, Han S, Qiang F, Wu Y, et al. Polymorphisms involved in the {miR-218-LAMB3} pathway and susceptibility of cervical cancer, a case-control study in Chinese women. Gynecol Oncol. 2010;117:287-290. doi: 10.1016/j.ygyno. 2010.01.020 PMID: 20163849
50. Kim JS, Choi YY, Jin G, Kang HG, Choi JE, Jeon HS, et al. Association of a common {AGO1} variant with lung cancer risk: a two-stage case-control study. Mol Carcinog. 2010;49:913-921. doi: 10.1002/mc.20672 PMID: 20721975
51. Zhang X, Yang H, Lee JJ, Kim E, Lippman SM, Khuri FR, et al. {MicroRNA-related} genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancer. Carcinogenesis. 2010;31:2118-2123. doi: 10.1093/carcin/bgq177 PMID: 20819778
52. Chen AX, Yu KD, Fan L, Li JY, Yang C, Huang AJ, et al. Germline genetic variants disturbing the Let-{7/LIN28} double-negative feedback loop alter breast cancer susceptibility. {PLoS} Genet. 2011;7:e1002259. doi: 10.1371/journal.pgen. 1002259 PMID: 21912531
53. Liu Z, Wei S, Ma H, Zhao M, Myers JN, Weber RS, et al. Afunctional variant at the {miR-184} binding sitein{TNFAIP2}and risk of squamous cell carcinoma of the head and neck. Carcinogenesis. 2011;32:1668-1674. doi: 10.1093/carcin/bgr209 PMID: 21934093
54. Permuth-Wey J, Kim D, Tsai Y, Lin H-Y, Chen YA, Barnholtz-Sloan J, et al. LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Res. 2011;71:3896-903. doi: 10.1158/0008-5472. CAN-10-4167 PMID: 21482675
55. Reshmi G, Surya R, Jissa VT, Babu PS, Preethi NR, Santhi WS, et al. C-T variant in a {miRNA} target site of {BCL2} is associated with increased risk of human papillomavirus related cervical cancer-an in silico approach. Genomics. 2011;98:189-193. doi: 10.1016/j.ygeno. 2011.06.005 PMID: 21704150
56. Xiong F, Wu C, Chang J, Yu D, Xu B, Yuan P, et al. Genetic variation in an {miRNA-1827} binding site in {MYCL1} alters susceptibility to small-cell lung cancer. Cancer Res. 2011;71:5175-5181. doi: 10. 1158/0008-5472. CAN-10-4407 PMID: 21676885
57. Sung H, Lee KM, Choi JY, Han S, Lee JY, Li L, et al. Common genetic polymorphisms of {microRNA} biogenesis pathway genes and risk of breast cancer: a case-control study in Korea. Breast Cancer Res Treat. 2011;130:939-951. doi: 10.1007/s10549-011-1656-2 PMID: 21766210
58. Xu Y, Liu L, Liu J, Zhang Y, Zhu J, Chen J, et al. A potentially functional polymorphism in the promoter region of {miR-34b/c} is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer. 2011;128:412-417. doi: 10.1002/ijc.25342 PMID: 20309940
59. Zhang L, Liu Y, Song F, Zheng H, Hu L, Lu H, et al. Functional {SNP} in the {microRNA-367} binding site in the {3'UTR} of the calcium channel ryanodine receptor gene 3 ({RYR3) } affects breast cancer risk and calcification. Proc Natl Acad Sci USA. 2011;108:13653-13658. doi: 10.1073/pnas. 1103360108 PMID: 21810988
60. Zheng H, Song F, Zhang L, Yang D, Ji P, Wang Y, et al. Genetic variants at the {miR-124} binding site on the cytoskeleton-organizing {IQGAP1} gene confer differential predisposition to breast cancer. Int J Oncol. 2011;38:1153-1161. doi: 10.3892/ijo.2011.940 PMID: 21318219
61. Bae JS, Kim JH, Pasaje CF, Cheong HS, Lee TH, Koh IS, et al. Association study of genetic variations in {microRNAs} with the risk of hepatitis B-related liver diseases. Dig Liver Dis. 2012;
62. Liu Y, Zhang Y, Wen J, Liu L, Zhai X, Liu J, et al. A genetic variant in the promoter region of {miR-106b-25} cluster and risk of {HBV} infection and hepatocellular carcinoma. {PLoS}One. 2012;7:e32230. doi: 10.1371/journal.pone.0032230 PMID: 22393390
63. Teo MT, Landi D, Taylor CF, Elliott F, Vaslin L, Cox DG, et al. The role of {microRNA-binding} site polymorphisms in {DNA} repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes. Carcinogenesis. 2012;33:581-586. doi: 10.1093/carcin/bgr300 PMID: 22166496
64. Yang L, Li Y, Cheng M, Huang D, Zheng J, Liu B, et al. Afunctional polymorphism at {microRNA-629-binding} site in the 3'-untranslated region of {NBS1} gene confers an increased risk of lung cancer in Southern and Eastern Chinese population. Carcinogenesis. 2012;33:338-347. doi: 10.1093/carcin/bgr272 PMID: 22114071
65. Moore AE, Young LE, Dixon DA. A common single-nucleotide polymorphism in cyclooxygenase-2 disrupts {microRNA-mediated} regulation. Oncogene. 2012;31:1592-1598. doi: 10.1038/onc.2011.349 PMID: 21822307
66. Yu Q, Zhou CX, Chen NS, Zheng SD, Shen LM, Zhang JK. A polymorphism within {ErbB4} is associated with risk for hepatocellular carcinoma in Chinese population. World J Gastroenterol. 2012;18:383-387. doi: 10.3748/wjg.v18.i4.383 PMID: 22294845
67. Zhang S, Chen H, Zhao X, Cao J, Tong J, Lu J, et al. {REV3L} {3'UTR} 460 T{\textgreater}C polymorphism in {microRNA} target sites contributes to lung cancer susceptibility. Oncogene. 2012;
68. Newton HJ, Baum C, Clayton D, Franklin C, Garrett JM, Gregory A, et al. Multiple-test procedures and smile plots. Stata J. 2003;3:109-132.
69. Glickman ME, Rao SR, Schultz MR. False discovery rate control is a recommended alternative to Bonferroni-type adjustments in health studies. J Clin Epidemiol. Elsevier Inc; 2014;67:850-857. doi: 10. 1016/j.jclinepi.2014.03.012 PMID: 24831050
70. Guo H, Wang K, Xiong G, Hu H, Wang D, Xu X, et al. Afunctional varient in {microRNA-146a} is associated with risk of esophageal squamous cell carcinoma in Chinese Han. Fam Cancer. 2010;9:599-603. doi: 10.1007/s10689-010-9370-5 PMID: 20680470
71. Wang K, Guo H, Hu H, Xiong G, Guan X, Li J, et al. Afunctional variation in pre-{microRNA-196a} is associated with susceptibility of esophageal squamous cell carcinoma risk in Chinese Han. Biomarkers. 2010;15:614-618. doi: 10.3109/1354750X.2010.505299 PMID: 20722507
72. Lee YH, Kim J-H, Song GG. Pathway analysis of a genome-wide association study in schizophrenia. Gene. 2013;525:107-15. doi: 10.1016/j.gene.2013.04.014 PMID: 23644028
73. Lagergren K, Lagergren J, Brusselaers N. Hormone replacement therapy and oral contraceptives and risk of oesophageal adenocarcinoma: A systematic review and meta-analysis. Int J Cancer. 2014;135:2183-90. doi: 10.1002/ijc.28869 PMID: 24676860
74. Cummings N, Shields KA, Curran JE, Bozaoglu K, Trevaskis J, Gluschenko K, et al. Genetic variation in SH3-domain GRB2-like (endophilin)-interacting protein 1 has a major impact on fat mass. Int J Obes (Lond). 2012;36:201-6. doi: 10.1038/ijo.2011.67 PMID: 21407171